<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842013/" ref="ordinalpos=3502&amp;ncbi_uid=5525296&amp;link_uid=PMC3842013" image-link="/pmc/articles/PMC3842013/figure/F3/" class="imagepopup">Figure 3. Beneficial and detrimental effects of adenosine <span class="highlight" style="background-color:">signaling</span> in sickle cell disease.  From: Adenosine <span class="highlight" style="background-color:">signaling</span> in normal and sickle erythrocytes and beyond. </a></div><br /><div class="p4l_captionBody">Elevated adenosine associated with SCD has beneficial effects by activating ADORA2A receptors on invariant natural killer T (iNKT) cells, a process that prevents iNKT cells activation and pulmonary inflammation. However, elevated adenosine activates ADORA2B receptors on erythrocytes thereby activating a signaling pathway leading to deoxy-HbS polymerization and erythrocyte sickling (see Fig. 2). The activation of ADORA2B receptors on penile endothelial cells and cavernosal smooth muscle cells results in priapism, a serious complication of SCD, leading to penile fibrosis and erectile dysfunction.</div></div>